{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:55:07Z","timestamp":1790690107477,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>Viruses are capable of inducing a wide spectrum of glomerular disorders that can be categorized on the basis of the duration of active viremia: acute, subacute, or chronic. The variable responses of the adaptive immune system to each time period of viral infection results mechanistically in different histologic forms of glomerular injury. The unique presence of a chronic viremic carrier state with either hepatitis C (HCV) or HIV has led to the opportunity to study in detail various pathogenic mechanisms of viral-induced glomerular injury, including direct viral infection of renal tissue and the development of circulating immune complexes composed of viral antigens that deposit along the glomerular basement membrane. Epidemiologic data show that approximately 25%\u201330% of all HIV patients are coinfected with HCV and 5%\u201310% of all HCV patients are coinfected with HIV. This situation can often lead to a challenging differential diagnosis when glomerular disease occurs in this dual-infected population and requires the clinician to be familiar with the clinical presentation, laboratory workup, and pathophysiology behind the development of renal disease for both HCV and HIV. Both of these viruses can be categorized under the new classification of infection-associated GN as opposed to being listed as causes of postinfectious GN as has previously been applied to them. Neither of these viruses lead to renal injury after a latent period of controlled and inactive viremia. The geneses of HCV- and HIV-associated glomerular diseases share a total dependence on the presence of active viral replication to sustain renal injury so the renal disease cannot be listed under \u201cpostinfectious\u201d GN. With the new availability of direct-acting antivirals for HCV and more effective combined antiretroviral therapy for HIV, successful remission and even regression of glomerular lesions can be achieved if initiated at an early stage.<\/jats:p>","DOI":"10.2215\/cjn.04320416","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T22:29:33Z","timestamp":1477348173000},"page":"1337-1342","source":"Crossref","is-referenced-by-count":43,"title":["Viral-Associated GN: Hepatitis C and HIV"],"prefix":"10.2215","volume":"12","author":[{"given":"Warren L.","family":"Kupin","sequence":"first","affiliation":[{"name":"Division of Nephrology, Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.shpsc.2016.02.009","article-title":"What is a virus species? Radical pluralism in viral taxonomy","volume":"59","author":"Morgan","year":"2016","journal-title":"Stud Hist Philos Biol Biomed Sci"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: roles of infection and autoimmunity","volume":"86","author":"Couser","year":"2014","journal-title":"Kidney Int"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1478-3231.2008.01672.x","article-title":"Renal hepatitis C in the absence of detectable serum or hepatic virus","volume":"28","author":"Fowell","year":"2008","journal-title":"Liver Int"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ki.2014.181","article-title":"Novel evidence on hepatitis C virus-associated glomerular disease","volume":"86","author":"Fabrizi","year":"2014","journal-title":"Kidney Int"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MEG.0000000000000236","article-title":"Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients","volume":"27","author":"Li","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/j.ijid.2013.01.017","article-title":"Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection","volume":"17","author":"Kong","year":"2013","journal-title":"Int J Infect Dis"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2014\/549624","article-title":"Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review","volume":"28","author":"Yau","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.gtc.2015.07.002","article-title":"Epidemiology of Hepatitis C Virus: A Battle on New Frontiers","volume":"44","author":"Shire","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","article-title":"Hepatitis C virus as a systemic disease: reaching beyond the liver","volume":"10","author":"Gill","year":"2016","journal-title":"Hepatol Int"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/acr.20381","article-title":"Hepatitis C virus-associated polyarteritis nodosa","volume":"63","author":"Saadoun","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/jvh.12414","article-title":"Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011","volume":"22","author":"Tong","year":"2015","journal-title":"J Viral Hepat"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13317-010-0005-5","article-title":"Hepatitis C virus and autoimmunity","volume":"1","author":"B\u00f6ckle","year":"2010","journal-title":"Auto Immun Highlights"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.3748\/wjg.v20.i24.7544","article-title":"Hepatitis C virus associated glomerulopathies","volume":"20","author":"Ozkok","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","article-title":"Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection","volume":"11","author":"Zignego","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.08.008","article-title":"Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature","volume":"65","author":"Terrier","year":"2015","journal-title":"J Autoimmun"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharm Des"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10238-016-0410-9","article-title":"Dammacco F, Racanelli V, Russi S, Sansonno D: The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review","volume":"16","year":"2016","journal-title":"Clin Exp Med"},{"key":"B18-20230813","first-page":"134","article-title":"Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy","volume":"3","author":"Tasleem","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1517\/14656566.2015.1066333","article-title":"Treatment of hepatitis C-related kidney disease","volume":"16","author":"Fabrizi","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(15)60658-4","article-title":"Defeating AIDS--advancing global health","volume":"386","author":"Piot","year":"2015","journal-title":"Lancet"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-med-041610-134224","article-title":"Recent progress in HIV-associated nephropathy","volume":"63","author":"Wyatt","year":"2012","journal-title":"Annu Rev Med"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfu391","article-title":"APOL1 nephropathy: from gene to mechanisms of kidney injury","volume":"31","author":"Kruzel-Davila","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrneph.2015.9","article-title":"HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment","volume":"11","author":"Rosenberg","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ki.2014.167","article-title":"Advances in the pathogenesis of HIV-associated kidney diseases","volume":"86","author":"Ross","year":"2014","journal-title":"Kidney Int"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.ki.5000339","article-title":"A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa","volume":"69","author":"Han","year":"2006","journal-title":"Kidney Int"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/ndt\/gft010","article-title":"The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans","volume":"28","author":"Fabian","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B29-20230813","first-page":"562790","article-title":"Nephrotoxicity of HAART","volume":"2011","author":"Kalyesubula","year":"2011","journal-title":"AIDS Res Treat"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2353\/ajpath.2010.100131","article-title":"HIV-associated nephropathy: role of mammalian target of rapamycin pathway","volume":"177","author":"Kumar","year":"2010","journal-title":"Am J Pathol"},{"key":"B31-20230813","first-page":"16","article-title":"The beneficial role of retinoids in glomerular disease","volume":"2","author":"Mallipattu","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.2215\/CJN.10991012","article-title":"Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy","volume":"8","author":"Foy","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33-20230813","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfv436","article-title":"HIV\/CKD Study and the UK CHIC Study: Clinical characteristics and outcomes of HIV-associated immune complex kidney disease","author":"Booth","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40620-016-0265-x","article-title":"IgA nephropathy and infections","volume":"29","author":"Rollino","year":"2016","journal-title":"J Nephrol"},{"issue":"5","key":"B35-20230813","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2015.216","article-title":"HIV-associated immune complex kidney disease","volume":"12","author":"Nobakht","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.2014.44","article-title":"The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy","volume":"86","author":"Mallipattu","year":"2014","journal-title":"Kidney Int"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfr676","article-title":"HIV-associated kidney glomerular diseases: changes with time and HAART","volume":"27","author":"Lescure","year":"2012","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201708000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:57Z","timestamp":1786369617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201708000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04320416","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}